FDA

Drug Approval Drug Approval Process Tobacco Products Tobacco Control Vaccine Approval Vaccine Approval Process Drug Safety Advisory Committees Cosmetic Regulations Tobacco Regulation

3 ARTICLES

6d ago

FDA Approves Moderna mRNA Flu Vaccine for Adults 50 and Older

The agency cleared the trivalent shot as a step toward faster strain updates, but formal use and payer coverage hinge on CDC advisory guidance that is currently stalled by a court dispute.

6 ARTICLES

last wk.

Youth Tobacco Use Falls to Multi-Year Low, But Vaping and Pouches Keep Risks High

7 ARTICLES

last mo.

FDA Agrees Three‑Year Phase I/II Data Can Support uniQure’s AMT‑130 Accelerated BLA

10 ARTICLES

2mo ago

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients, First New Filter in Over 20 Years

46 ARTICLES

2mo ago

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients

5 ARTICLES

2mo ago

Study Finds Vaping Alters 3,124 Genes and Flavors Drive Most Changes

3 ARTICLES

2mo ago

FDA Clears Tempus xT CDx to Run as Tumor‑Only Diagnostic

6 ARTICLES

3mo ago

Atara Faces Investor Class Action Over FDA Rejections of EBVALLO

4 ARTICLES

3mo ago

Compass Pathways Rises on Q1 Beat as FDA Accepts Rolling Review for COMP360

5 ARTICLES

3mo ago

FDA

FDA Approves Moderna mRNA Flu Vaccine for Adults 50 and Older

FDA Authorizes Four Flavored Nicotine Pouches as Health Groups Raise Alarms

Moderna Posts Q2 Revenue Beat as Norovirus Trial Misses Interim Goal

FDA Advisory Panel Recommends Six Peptides for Pharmacy Compounding

FDA Staff Flags Major Flaws in Capricor’s Deramiocel Data

FDA Advisory Panel Recommends Allowing Two Unproven Peptides in Pharmacies

FDA Advisers Recommend BPC-157 for Pharmacy Compounding

Kalshi Opens Betting Markets for Phase 3 Drug Trials and FDA Decisions

FDA Says Metals Found in Tampons Are Not at Harmful Levels

FDA Authorizes Zyn to Market Reduced‑Risk Claims for 20 Nicotine Pouch Products

Never miss stories about

FDA

FDA Allows Zyn to Be Marketed as Lower Risk Than Cigarettes

Youth Tobacco Use Falls to Multi-Year Low, But Vaping and Pouches Keep Risks High

FDA Agrees Three‑Year Phase I/II Data Can Support uniQure’s AMT‑130 Accelerated BLA

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients, First New Filter in Over 20 Years

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients

Study Finds Vaping Alters 3,124 Genes and Flavors Drive Most Changes

FDA Clears Tempus xT CDx to Run as Tumor‑Only Diagnostic

Atara Faces Investor Class Action Over FDA Rejections of EBVALLO

Compass Pathways Rises on Q1 Beat as FDA Accepts Rolling Review for COMP360

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

Never miss stories about

FDA